 Teicoplanin pharmacokinetics intravenous drug abusers bacterial endocarditis pharmacokinetics teicoplanin multiple intravenous infusions mg/kg intravenous drug abuse IVDA patients bacterial endocarditis Multiple serum samples days Twenty-four-hour urine collections days concentration-time data multiple-dose pharmacokinetic analysis Results pharmacokinetic parameters previous studies normal healthy volunteers multiple intravenous infusions teicoplanin mg/kg/day Total renal clearances teicoplanin IVDA patients variable observed normal healthy volunteers result steady-state trough concentrations serum mechanism responsible variation glomerular filtration rate IVDA patients teicoplanin dosage treatment bacterial endocarditis